Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future.
<p>Metabolomics and lipidomics are emerging methods for detailed phenotyping of small molecules in samples. It is hoped that such data will i) enhance baseline prediction of patient response to pharmacotherapies (beneficial or adverse)c ii) reveal changes in metabolites shortly after initiatio...
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Kieli: | English |
| Julkaistu: |
Oxford University Press
2016
|